IDiyas

For the Inventor, By the Inventor

New York, NY, United States of America

Beyondspring Pharmaceuticals, Inc.


USPTO Granted Patents = 21


Trademarks = 3

Forward Citations = 136

Loading Chart...
Loading Chart...

9 inventors (with patents filed for the assignee):

goldMedal Lan Huang (20 out of 23 patents)

silverMedal Ramon Mohanlal (8 out of 8 patents)

bronzeMedal George Kenneth Lloyd (8 out of 12 patents)

4.  Aniruddh Singh (4 out of 7 patents)

5.  Michel O Steinmetz (2 out of 2 patents)

6.  Santosh Ambadas Khedkar (2 out of 6 patents)

7.  Michael A Palladino (1 out of 24 patents)

8.  Yoshio Hayashi (1 out of 10 patents)

9.  James R Tonra (1 out of 1 patent)

10.  Michel O Steinmetz (0 patent)


21 patents:

1. 12458639 - Tubulin binding compounds and therapeutic use thereof (2025-11-04),
2. 12458638 - Method of stimulating neutrophil survival and reducing neutropenia (2025-11-04),
3. 12433886 - Composition and method for reducing neutropenia (2025-10-07),
4. 12377094 - Therapeutic compositions and methods for treating checkpoint inhibitor-resistant tumors using plinabulin-based combination therapies (2025-08-05),
5. 12024501 - Plinabulin compositions (2024-07-02),
6. 11918574 - Method of treating cancer associated with a RAS mutation (2024-03-05),
7. 11857522 - Compositions containing tucaresol or its analogs (2024-01-02),
8. 11786523 - Composition and method for reducing thrombocytopenia (2023-10-17),
9. 11633393 - Tubulin binding compounds and therapeutic use thereof (2023-04-25),
10. 11400086 - Method of reducing chemotherapy-induced neutropenia (2022-08-02),
11. 11254657 - Plinabulin compositions (2022-02-22),
12. 11229642 - Composition and method for reducing neutropenia (2022-01-25),
13. 11045467 - Method of treating cancer associated with a RAS mutation (2021-06-29),
14. 10912748 - Compositions containing tucaresol or its analogs (2021-02-09),
15. 10668063 - Method of treating cancer associated with a RAS mutation (2020-06-02),
BeyondSpring Pharmaceuticals, Inc. is a global biopharmaceutical company focused on the development of innovative cancer therapies. With a mission to improve patient outcomes, BeyondSpring is dedicated to bringing novel treatment options to patients with unmet medical needs. By leveraging cutting-edge science and technology, the company aims to create transformative therapies that target the underlying mechanisms of cancer and enhance the body's immune system to fight against the disease. With a strong pipeline of drug candidates, BeyondSpring is committed to advancing the field of oncology and making a meaningful impact on the lives of patients worldwide.
This text is generated by artificial intelligence and may not be accurate.

logo

Company Badge

USPTO Data Jan 1 1976 - Dec 9 2025

21 Patents

#341 in New York, NY

#848 in New York

#15,151 in US

#29,031 in the World

...
New York, NY, United States of America

Beyondspring Pharmaceuticals, Inc.

Forward Citations = 136

9 inventors:

goldMedal Lan Huang (20 out of 23 patents)

silverMedal Ramon Mohanlal (8 out of 8 patents)

bronzeMedal George Kenneth Lloyd (8 out of 12 patents)

4.  Aniruddh Singh (4 out of 7 patents)

5.  Michel O Steinmetz (2 out of 2 patents)

Please report any incorrect information to support@idiyas.com
Loading…